The goal of the study was to determine if bulbospinal neurons, which supplies information to preganglionic neurons of the sympathetic nervous systems [62], respond to SGLT2 and SGLT1 inhibitors and thus alleviate hypertension by weakening activity in the sympathetic nervous system [63]. This evidence concerns the gene SLC5A2 and hypertensive disorder.